GO:0120274 virus coreceptor activity: Mechanism, Genes

Virus coreceptor activity (GO:0120274) is a molecular function that describes the binding of a virus component to a cell surface molecule that acts in concert with a primary receptor to trigger a change in cell activity, typically initiating viral entry. This term is fundamental to understanding how enveloped viruses, such as human immunodeficiency virus type 1 (HIV-1), gain access to host cells. HIV-1 entry requires the primary receptor CD4 and a coreceptor, most commonly CCR5 or CXCR4, and the choice of coreceptor dictates viral tropism and disease progression [5,7]. The interaction between the viral envelope glycoprotein and the coreceptor is a key determinant of host range and pathogenesis. Research on virus coreceptor activity has broad implications beyond HIV-1. For example, adenovirus endocytosis involves a series of interactions with cell surface molecules that facilitate internalization, and these processes are studied as models for coreceptor-mediated entry [2,3]. The concept of coreceptor activity also extends to other viruses, where cooperation between multiple receptors is required for efficient infection. Understanding these mechanisms is essential for the development of antiviral drugs that target entry steps, as well as for interpreting viral immune responses and pathogenesis [1,6]. In the era of CRISPR gene editing, the ability to precisely manipulate genes encoding coreceptors and primary receptors has accelerated functional studies. Knockout, point mutation, and knock-in models allow researchers to dissect the specific contributions of individual domains and residues to coreceptor function. This article provides a comprehensive overview of the biology, genetics, and research methods associated with GO:0120274, with a focus on publication-ready insights for biomedical researchers.

According to the Gene Ontology, virus coreceptor activity (GO:0120274) is defined as the molecular function of combining with a virus component and, in cooperation with a nearby primary receptor, initiating a change in cell activity. This activity is typically mediated by cell surface proteins that, upon binding to viral ligands, facilitate conformational changes or signaling events that lead to viral entry or other cellular responses. The term is synonymous with viral coreceptor activity and is classified under molecular_function.

Virus coreceptor activity is a critical determinant of viral tropism, host range, and pathogenesis. For HIV-1, the use of CCR5 or CXCR4 as a coreceptor defines viral tropism and is associated with different stages of disease. The interaction between the viral envelope protein and the coreceptor is a prime target for entry inhibitors, and understanding this activity is essential for developing novel antiviral therapies. Moreover, coreceptor usage can influence immune responses and disease progression, as seen in SARS-CoV-2 infection where specific immune responses and pathogenesis are linked to viral entry mechanisms. Thus, studying virus coreceptor activity provides insights into fundamental virology and translational applications.

The following genes encode proteins that function as virus coreceptors or primary receptors in viral entry, and are frequently studied in the context of GO:0120274.

The expression and function of virus coreceptors are regulated at multiple levels. Transcriptional regulation by cytokines and chemokines can alter coreceptor levels on the cell surface. For example, CCR5 expression is modulated by inflammatory signals, and its ligand RANTES can downregulate its availability. Post-translational modifications, such as sulfation of tyrosine residues, are critical for coreceptor activity; CXCR4 sequences involved in coreceptor determination include sulfated tyrosines that enhance binding to HIV-1 Env. Additionally, coreceptor function can be regulated by interaction with other cell surface molecules and by intracellular trafficking. The actin cytoskeleton and cofilin-mediated actin dynamics have been implicated in regulating coreceptor engagement and viral entry. Understanding these regulatory mechanisms is important for therapeutic targeting.

HIV-1 infection depends on the sequential interaction with CD4 and a coreceptor, primarily CCR5 or CXCR4. The switch from CCR5 to CXCR4 usage is associated with accelerated disease progression and poor prognosis. Individuals homozygous for a 32-base pair deletion in CCR5 (CCR5-delta32) are resistant to R5-tropic HIV-1 infection, demonstrating the critical role of coreceptors in disease susceptibility. Coreceptor antagonists, such as maraviroc, are used clinically to block CCR5-mediated entry.

Beyond HIV-1, many viruses utilize coreceptors for entry. Adenoviruses interact with integrins and other molecules for endocytosis, and these interactions are studied as models for coreceptor activity [2,3]. SARS-CoV-2 uses ACE2 as a primary receptor, but neuropilin-1 and other molecules may act as coreceptors or entry enhancers. The immune response to SARS-CoV-2 and its pathogenesis are influenced by viral entry mechanisms, highlighting the broader relevance of coreceptor activity.

Coreceptor activity is a validated target for antiviral therapy. Small molecule inhibitors that bind to CCR5 or CXCR4 can block HIV-1 entry. Imidazolidinones and imidazolidine-2,4-diones have been explored as antiviral agents that may interfere with coreceptor interactions. Understanding the structural determinants of coreceptor function, such as the CXCR4 sequences involved in tropism, can guide rational drug design.

CRISPR-Cas9 knockout of candidate coreceptor genes is a powerful method to assess their requirement for viral entry. For example, knockout of CCR5 in CD4+ T cells renders them resistant to R5-tropic HIV-1. RNA interference (RNAi) can also be used for transient knockdown. These approaches help establish causality between coreceptor expression and viral infection.

Viral entry can be measured using pseudotyped viruses carrying reporter genes (e.g., luciferase) and specific envelope proteins. Binding assays, such as flow cytometry with soluble envelope proteins or virus-like particles, can quantify coreceptor engagement. Cell-cell fusion assays are used to study coreceptor-dependent membrane fusion, as demonstrated with simian immunodeficiency virus Env proteins.

Site-directed mutagenesis of coreceptor genes, followed by functional assays, identifies critical residues. For instance, mutation of tyrosine sulfation sites in CXCR4 affects coreceptor activity. Structural studies using cryo-EM or X-ray crystallography can reveal the interface between viral envelope proteins and coreceptors, guiding drug design.

Genome-wide CRISPR knockout or activation screens can identify novel coreceptors or regulators of viral entry. Cells are transduced with a library, selected with a virus, and surviving cells are sequenced to identify enriched or depleted sgRNAs. This unbiased approach has been used to discover host factors for various viruses, including SARS-CoV-2.

Researchers studying virus coreceptor activity-related genes often need to determine whether a candidate gene is causally involved in viral entry, tropism, or pathogenesis. EDITGENE provides a comprehensive suite of CRISPR-based services to create precisely engineered cell models, enabling rigorous functional studies.

Virus coreceptor activity (GO:0120274) is a fundamental molecular function that governs viral entry and tropism for many clinically important viruses. The interaction between viral envelope proteins and coreceptors such as CCR5 and CXCR4 is a key determinant of HIV-1 pathogenesis and a validated drug target [5,6]. Advances in CRISPR gene editing have enabled precise dissection of coreceptor function, from residue-level analysis to genome-wide screens [7,1]. Understanding these mechanisms not only informs antiviral strategies but also sheds light on basic cell biology and immune responses. Continued research using engineered cell models will further elucidate the complexities of coreceptor activity and its role in disease.